Why is Wuhan Dapeng Pharmaceutical not listed?

The reason why Wuhan Dapeng Pharmaceutical is not listed is that it does not want to be controlled by capital. Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd. will not be listed independently. In the near future, Jianmin Group will acquire the remaining 66% of the shares, and Huali Group can't lose the right to deal with the bezoar in vitro of Jianmin Dapeng through private placement and share swap. If it is listed independently, it will definitely dilute the equity and fail to reach the current one-vote veto of 33.54%. At present, the strength of Wuhan Dapeng Pharmaceutical Co., Ltd., the major shareholder, is far less than that of Huali Group. If Jianmin Dapeng Pharmaceutical becomes a wholly-owned subsidiary of Jianmin Group, it will contribute to the development of a series of products such as bezoar in vitro. Choubao, Angong and Niuhuang Qingxin Pills can all be branded as Jianmin Group, and their popularity is higher.